Parkinson’s Disease Treatment Market Size, Share & Trends Report

Parkinson’s Disease Treatment Market Size, Share & Trends Analysis Report By Drug Class (Carbidopa-levodopa, Anticholinergics), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Region, And Segment Forecasts, 2022 - 2030

Report ID: GVR-4-68039-990-7
Number of Pages: 100
Format: Electronic (PDF)

Historical Range: 2018 - 2020
Industry:Healthcare

Market Segmentation

PD Treatment Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
- Carbidopa-Levodopa
- Dopamine Agonists
- MAO-B Inhibitors
- COMT Inhibitors
- Anticholinergics
- Others
PD Treatment Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
- Hospital Pharmacy
- Specialty Pharmacy
- 网上药店
PD Treatment Regional Outlook (Revenue, USD Million, 2018- 2030)
- North America
  - North America Parkinson’s Disease Treatment Market, By Drug Class
    - Carbidopa-Levodopa
    - Dopamine Agonists
    - MAO-B Inhibitors
    - COMT Inhibitors
    - Anticholinergics
    - Others
  - North America Parkinson’s Disease Treatment Market, By Distribution Channel
    - Hospital Pharmacy
    - Retail Pharmacy
    - 网上药店
  - U.S.
    - U.S. Parkinson’s Disease Treatment Market, By Drug Class
      - Carbidopa-Levodopa
      - Dopamine Agonists
      - MAO-B Inhibitors
      - COMT Inhibitors
      - Anticholinergics
      - Others
    - U.S. Parkinson’s Disease Treatment Market, By Distribution Channel
      - Hospital Pharmacy
      - Retail Pharmacy
      - 网上药店
  - Canada
    - Canada Parkinson’s Disease Treatment Market, By Drug Class
      - Carbidopa-Levodopa
      - Dopamine Agonists
      - MAO-B Inhibitors
      - COMT Inhibitors
      - Anticholinergics
      - Others
    - Canada Parkinson’s Disease Treatment Market, By Distribution Channel
      - Hospital Pharmacy
      - Retail Pharmacy
      - 网上药店
- Europe
  - Europe Parkinson’s Disease Treatment Market, By Drug Class
    - Carbidopa-Levodopa
    - Dopamine Agonists
    - MAO-B Inhibitors
    - COMT Inhibitors
    - Anticholinergics
    - Others
  - Europe Parkinson’s Disease Treatment Market, By Distribution Channel
    - Hospital Pharmacy
    - Retail Pharmacy
    - 网上药店
  - U.K.
    - U.K. Parkinson’s Disease Treatment Market, By Drug Class
      - Carbidopa-Levodopa
      - Dopamine Agonists
      - MAO-B Inhibitors
      - COMT Inhibitors
      - Anticholinergics
      - Others
    - U.K. Parkinson’s Disease Treatment Market, By Distribution Channel
      - Hospital Pharmacy
      - Retail Pharmacy
      - 网上药店
  - Germany
    - Germany Parkinson’s Disease Treatment Market, By Drug Class
      - Carbidopa-Levodopa
      - Dopamine Agonists
      - MAO-B Inhibitors
      - COMT Inhibitors
      - Anticholinergics
      - Others
    - Germany Parkinson’s Disease Treatment Market, By Distribution Channel
      - Hospital Pharmacy
      - Retail Pharmacy
      - 网上药店
  - Italy
    - Italy Parkinson’s Disease Treatment Market, By Drug Class
      - Carbidopa-Levodopa
      - Dopamine Agonists
      - MAO-B Inhibitors
      - COMT Inhibitors
      - Anticholinergics
      - Others
    - Italy Parkinson’s Disease Treatment Market, By Distribution Channel
      - Hospital Pharmacy
      - Retail Pharmacy
      - 网上药店
  - France
    - France Parkinson’s Disease Treatment Market, By Drug Class
      - Carbidopa-Levodopa
      - Dopamine Agonists
      - MAO-B Inhibitors
      - COMT Inhibitors
      - Anticholinergics
      - Others
    - France Parkinson’s Disease Treatment Market, By Distribution Channel
      - Hospital Pharmacy
      - Retail Pharmacy
      - 网上药店
  - Spain
    - Spain Parkinson’s Disease Treatment Market, By Drug Class
      - Carbidopa-Levodopa
      - Dopamine Agonists
      - MAO-B Inhibitors
      - COMT Inhibitors
      - Anticholinergics
      - Others
    - Spain Parkinson’s Disease Treatment Market, By Distribution Channel
      - Hospital Pharmacy
      - Retail Pharmacy
      - 网上药店
- Asia Pacific
  - Asia Pacific Parkinson’s Disease Treatment Market, By Drug Class
    - Carbidopa-Levodopa
    - Dopamine Agonists
    - MAO-B Inhibitors
    - COMT Inhibitors
    - Anticholinergics
    - Others
  - Asia Pacific Parkinson’s Disease Treatment Market, By Distribution Channel
    - Hospital Pharmacy
    - Retail Pharmacy
    - 网上药店
  - Japan
    - Japan Parkinson’s Disease Treatment Market, By Drug Class
      - Carbidopa-Levodopa
      - Dopamine Agonists
      - MAO-B Inhibitors
      - COMT Inhibitors
      - Anticholinergics
      - Others
    - Japan Parkinson’s Disease Treatment Market, By Distribution Channel
      - Hospital Pharmacy
      - Retail Pharmacy
      - 网上药店
  - China
    - China Parkinson’s Disease Treatment Market, By Drug Class
      - Carbidopa-Levodopa
      - Dopamine Agonists
      - MAO-B Inhibitors
      - COMT Inhibitors
      - Anticholinergics
      - Others
    - China Parkinson’s Disease Treatment Market, By Distribution Channel
      - Hospital Pharmacy
      - Retail Pharmacy
      - 网上药店
  - India
    - India Parkinson’s Disease Treatment Market, By Drug Class
      - Carbidopa-Levodopa
      - Dopamine Agonists
      - MAO-B Inhibitors
      - COMT Inhibitors
      - Anticholinergics
      - Others
    - India Parkinson’s Disease Treatment Market, By Distribution Channel
      - Hospital Pharmacy
      - Retail Pharmacy
      - 网上药店
  - Australia
    - Australia Parkinson’s Disease Treatment Market, By Drug Class
      - Carbidopa-Levodopa
      - Dopamine Agonists
      - MAO-B Inhibitors
      - COMT Inhibitors
      - Anticholinergics
      - Others
    - Australia Parkinson’s Disease Treatment Market, By Distribution Channel
      - Hospital Pharmacy
      - Retail Pharmacy
      - 网上药店
  - South Korea
    - South Korea Parkinson’s Disease Treatment Market, By Drug Class
      - Carbidopa-Levodopa
      - Dopamine Agonists
      - MAO-B Inhibitors
      - COMT Inhibitors
      - Anticholinergics
      - Others
    - South Korea Parkinson’s Disease Treatment Market, By Distribution Channel
      - Hospital Pharmacy
      - Retail Pharmacy
      - 网上药店
- Latin America
  - Latin America Parkinson’s Disease Treatment Market, By Drug Class
    - Carbidopa-Levodopa
    - Dopamine Agonists
    - MAO-B Inhibitors
    - COMT Inhibitors
    - Anticholinergics
    - Others
  - Latin America Parkinson’s Disease Treatment Market, By Distribution Channel
    - Hospital Pharmacy
    - Retail Pharmacy
    - 网上药店
  - Brazil
    - Brazil Parkinson’s Disease Treatment Market, By Drug Class
      - Carbidopa-Levodopa
      - Dopamine Agonists
      - MAO-B Inhibitors
      - COMT Inhibitors
      - Anticholinergics
      - Others
    - Brazil Parkinson’s Disease Treatment Market, By Distribution Channel
      - Hospital Pharmacy
      - Retail Pharmacy
      - 网上药店
  - Mexico
    - Mexico Parkinson’s Disease Treatment Market, By Drug Class
      - Carbidopa-Levodopa
      - Dopamine Agonists
      - MAO-B Inhibitors
      - COMT Inhibitors
      - Anticholinergics
      - Others
    - Mexico Parkinson’s Disease Treatment Market, By Distribution Channel
      - Hospital Pharmacy
      - Retail Pharmacy
      - 网上药店
  - Argentina
    - Argentina Parkinson’s Disease Treatment Market, By Drug Class
      - Carbidopa-Levodopa
      - Dopamine Agonists
      - MAO-B Inhibitors
      - COMT Inhibitors
      - Anticholinergics
      - Others
    - Argentina Parkinson’s Disease Treatment Market, By Distribution Channel
      - Hospital Pharmacy
      - Retail Pharmacy
      - 网上药店
- MEA
  - MEA Parkinson’s Disease Treatment Market, By Drug Class
    - Carbidopa-Levodopa
    - Dopamine Agonists
    - MAO-B Inhibitors
    - COMT Inhibitors
    - Anticholinergics
    - Others
  - MEA Parkinson’s Disease Treatment Market, By Distribution Channel
    - Hospital Pharmacy
    - Retail Pharmacy
    - 网上药店
  - South Africa
    - South Africa Parkinson’s Disease Treatment Market, By Drug Class
      - Carbidopa-Levodopa
      - Dopamine Agonists
      - MAO-B Inhibitors
      - COMT Inhibitors
      - Anticholinergics
      - Others
    - South Africa Parkinson’s Disease Treatment Market, By Distribution Channel
      - Hospital Pharmacy
      - Retail Pharmacy
      - 网上药店
  - Saudi Arabia
    - Saudi Arabia Parkinson’s Disease Treatment Market, By Drug Class
      - Carbidopa-Levodopa
      - Dopamine Agonists
      - MAO-B Inhibitors
      - COMT Inhibitors
      - Anticholinergics
      - Others
    - Saudi Arabia Parkinson’s Disease Treatment Market, By Distribution Channel
      - Hospital Pharmacy
      - Retail Pharmacy
      - 网上药店
  - 阿联酋
    - 阿联酋Parkinson’s Disease Treatment Market, By Drug Class
      - Carbidopa-Levodopa
      - Dopamine Agonists
      - MAO-B Inhibitors
      - COMT Inhibitors
      - Anticholinergics
      - Others
    - 阿联酋Parkinson’s Disease Treatment Market, By Distribution Channel
      - Hospital Pharmacy
      - Retail Pharmacy
      - 网上药店

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
乐鱼体育手机网站入口
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
竞争格局
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report -free of charge- including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read ourprivacy policy.